Silvia Millán Martín, Ph.D.

Silvia obtained her BSc and PhD in Pharmacy from University of the Basque Country (Spain). She joined NIBRT in 2012 becoming part of the GlycoScience group, as a Mass Spec specialist working on academic and contract research projects with Biopharma companies. Her work focused on biotherapeutic characterisation by LC-MS platforms. In September 2016 she joined CCL team as a Research Scientist to collaborate with Thermo Fisher Scientific on the development of new applications for the full characterisation of biotherapeutic products including mAbs, bispecific antibodies (BsAbs) or fusion proteins. During last few years, her work focuses on the MAM approach and the application of LCMS to support the development of new therapeutic modalities (bispecific Abs, AAVs or RNA-based therapeutics).